Skip to main content
SpringerLink
Log in

Questions and Answers

  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wikby A, Stenström U, Hörnquist JO, et al. Coping behavior and degree of discrepancy between retrospective and prospective self-ratings of change in quality of life in Type I diabetes mellitus. Diabetic Med 1993; 10: 851–4

    Article  PubMed  CAS  Google Scholar 

  2. Bendtsen P, Hörnquist JO. Change and status in quality of life in patients with rheumatoid arthritis. Qual Life Res 1992; 1: 297–305

    Article  Google Scholar 

  3. Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995; 47: 1703–20

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Questions and Answers. Pharmacoeconomics 8 (Suppl 1), 85–91 (1995). https://doi.org/10.2165/00019053-199500081-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199500081-00018

Keywords

Search

Navigation